Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesGeneral Surgerymediviewcurative exploratory laparotomy Coverage |…
    Ask Trek AI about this page
    CurrentmediviewcurativePolicy N/A

    Other inpatient surgical procedures — exploratory laparotomy and damage-control surgery

    Customize your policy alerts

    Sign up for all mediviewcurative policy alerts

    Know when mediviewcurative releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines inpatient utilization-management criteria for exploratory laparotomy (trauma/acute abdomen) and damage-control (abbreviated) laparotomy, including admission, discharge, continued-stay, coding crosswalks, and level-of-care guidance for Curative Health Plan.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Policy Summary
    Payermediviewcurative
    PolicyOther inpatient surgical procedures — exploratory laparotomy and damage-control surgery
    Policy CodePolicy N/A
    Change TypeNo material clinical or coverage changes
    Effective DateMar 4, 2026
    Last ReviewMar 4, 2026
    Next Review DateN/A
    Key ActionDocument diagnosis codes and procedure justification and include required admission or extended-stay triggers with supporting clinical evidence and a targeted intervention plan.
    SourceLink
    6conditions/procedures in this section
    Goal LOS 3-7dUncomplicated exploratory laparotomy
    Goal LOS 7-14dUncomplicated damage-control surgery
    ≥14dPre-op alpha-blockade for pheochromocytoma
    49000-49010CPT range cited

    Inpatient Coverage Criteria

    inv-01: Exploratory laparotomy — Admission — Covered when ALL of the following apply:

    Covered when ALL of the following apply:

    Exploratory laparotomy admission: Severity of illness indicates ALWAYS INPATIENT: acute abdomen with peritonitis requiring emergent surgical exploration OR penetrating abdominal trauma with hemodynamic instability or peritonitis OR blunt abdominal trauma with positive FAST and hemodynamic instability OR pneumoperitoneum on imaging OR evisceration; AND Intensity of Service: meet >=1 - surgical procedure requiring post-operative inpatient recovery OR post-operative monitoring (hemodynamics, wound/drain management) OR post-operative services not available at outpatient/observation level.

    From Section A.

    inv-02: Damage-control surgery — Admission — Covered when ALL of the following apply:

    Covered when ALL of the following apply:

    Damage-control surgery admission: Severity of illness indicates ALWAYS INPATIENT/ICU: massive trauma with lethal triad (hypothermia <35°C; acidosis pH <7.2; coagulopathy INR >1.5) OR need for rapid hemorrhage and contamination control with temporary abdominal closure and planned return to OR in 24-72h; AND Intensity of Service: meet >=1 - surgical procedure requiring post-operative inpatient recovery OR post-operative monitoring (hemodynamics, wound/drain management) OR post-operative services not available at outpatient/observation level.

    From Section A; lethal triad thresholds cited.

    inv-03: Retroperitoneal sarcoma: Admission/medical necessity criteria — admission covered when ALL severity criteria and at least ONE intensity-of-service criterion are met

    Admission for retroperitoneal sarcoma is covered when ALL of the following severity criteria are met and at least ONE intensity-of-service criterion is present.

    Severity of Illness (ALL): biopsy-confirmed retroperitoneal sarcoma (e.g., liposarcoma, leiomyosarcoma, MPNST); imaging confirms resectable disease (CT/MRI abdomen/pelvis); NCCN-recommended surgical resection with goal of R0 margins; sarcoma multidisciplinary tumor board

    All severity items required.

    Intensity of Service (>=1): surgical procedure requiring post-operative inpatient recovery; post-operative monitoring: hemodynamics, wound/drain management; post-operative services not available at outpatient/observation level

    At least one intensity criterion required.

    inv-04: Pheochromocytoma resection: Admission/medical necessity criteria — covered when ALL severity criteria and at least ONE intensity-of-service criterion are met

    Admission for pheochromocytoma resection is covered when ALL severity criteria are met and at least ONE intensity-of-service criterion is present.

    Severity of Illness (ALL): biochemically confirmed pheochromocytoma (elevated plasma/urine metanephrines/catecholamines); imaging-confirmed adrenal mass on CT/MRI; adequate alpha-blockade pre-operatively (≥14 days of phenoxybenzamine or doxazosin followed by beta-blockade and volume expansion); anesthesia team experienced in pheochromocytoma management>= 14 days (alpha-blockade)

    All severity items required; pre-op optimization cited.

    Intensity of Service (>=1): surgical procedure requiring post-operative inpatient recovery; post-operative monitoring: hemodynamics, wound/drain management; post-operative services not available at outpatient/observation level

    At least one intensity criterion required.

    inv-05: Extended stay criteria — Continued inpatient stay beyond goal LOS covered when ONE OR MORE documented medical-necessity triggers are present

    Continued inpatient stay beyond goal LOS is covered when ONE OR MORE of the following documented medical-necessity triggers are present and accompanied by clinical evidence and a targeted intervention plan.

    Extended-stay triggers: anastomotic leak requiring imaging, drainage, or revision; postoperative ileus >5 days requiring NG decompression and TPN; surgical site infection or wound dehiscence; pancreatic fistula (post-Whipple/distal pancreatectomy) ISGPF grade B/C; bile leak requiring drainage or ERCP; post-op hemorrhage requiring transfusion or re-operationONE OR MORE

    Document specific trigger, supporting clinical evidence, and targeted intervention plan.

    inv-06: COVERAGE CRITERIA — general covered when ALL of the following are met for inpatient admission and stay documentation

    Covered when ALL of the following are met for inpatient admission and stay documentation:

    pheo_admission: Procedure requires inpatient post-operative recovery due to risk of intraoperative hemodynamic lability and need for ICU/post-op monitoring and glucose monitoring (rebound hypoglycemia); documentation must support severity of illness and intensity of service.

    See DRG/CPT crosswalk and ICU considerations.

    pheo_extended_stay_triggers: Extended stay requires documentation of one or more medical-necessity triggers

    Examples: neck hematoma requiring evacuation; persistent hypocalcemia requiring IV calcium; recurrent laryngeal nerve injury with airway concerns; pheochromocytoma post-op hemodynamic instability beyond 48 h.

    inv-07: Inpatient parathyroidectomy for hypercalcemic crisis — Covered when ALL of the following are met

    Covered when ALL of the following are met:

    parathyroid_admission: Patient meets severity of illness criteria: hypercalcemic crisis defined as Ca >14 mg/dL with altered mental status, cardiac arrhythmia, or dehydration requiring IV fluid resuscitation and medical therapy (calcitonin, bisphosphonate) OR has concurrent medical comorbidities requiring inpatient monitoring OR mediastinal exploration is required; AND Intensity of Service: surgical procedure requiring post-operative inpatient recovery OR post-operative monitoring OR post-operative services not available at outpatient/observation level.Ca >14 mg/dL

    Routine parathyroidectomy is outpatient; inpatient only for hypercalcemic crisis or other inpatient needs.

    inv-08: Standalone oncologic lymph node dissection — Covered when ALL of the following are met

    Covered when ALL of the following are met:

    lymphnode_admission: Clinically positive lymph nodes confirmed by biopsy (FNA or core) in melanoma, SCC, breast, GU, or gynecologic cancers OR completion lymph node dissection after positive sentinel node biopsy when indicated per NCCN; AND Intensity of Service: surgical procedure requiring post-operative inpatient recovery OR post-operative monitoring (hemodynamics, wound/drain management) OR post-operative services not available at outpatient/observation level.

    Therapeutic lymphadenectomy for biopsy-confirmed node-positive disease; sentinel node biopsy alone is outpatient unless other factors justify inpatient care.

    inv-09: Continued stay and Extended Stay Criteria — daily surgical team review required and when Goal LOS is exceeded ONE OR MORE triggers required

    Continued inpatient stay requires daily surgical team review and documentation of clinical reasons; when Goal LOS is exceeded, ONE OR MORE of the following triggers must be documented with supporting evidence and an intervention plan.

    Continued stay prerequisites: Daily surgical team review; presence of postoperative complications (wound infection, hemorrhage, anastomotic leak, ileus, DVT/PE, AKI, arrhythmia), inability to meet functional milestones, or need for medical co-management of unstable comorbidities

    From Continued Stay / Concurrent Review section.

    Extended stay medical-necessity triggers: Free flap compromise requiring re-exploration or revision; tracheostomy site bleeding or infection; inability to swallow or manage secretions delaying decannulation; wound dehiscence or fistula formation (orocutaneous, pharyngocutaneous); failure of caregiver to demonstrate tracheostomy and/or tube feed competencyONE OR MORE

    Documentation must state specific trigger, supporting clinical evidence, and targeted intervention plan.

    Admissions for procedures that can be performed safely in an ambulatory surgery center with same‑day discharge are not appropriate for inpatient status. Examples include diagnostic procedures alone that do not require overnight recovery. Also included are pre‑operative admissions >1 day before surgery for non‑medical reasons (admit day of surgery unless medical optimization is required), continued post‑operative stays when all discharge criteria are met, continued stays solely awaiting facility placement when the member is medically ready, and post‑operative stays that extend beyond the expected length of stay without documented medical justification.

    Damage‑control surgery does not meet inpatient criteria when the procedure or related care could be completed in an ambulatory surgery center with same‑day discharge or when the admission is solely for a diagnostic procedure that does not require overnight recovery. Pre‑operative admission more than one day before the scheduled surgery for non‑medical reasons should be avoided (admit the day of surgery unless medical optimization is necessary). Continued post‑operative stays that meet all discharge criteria, stays solely awaiting placement once medically ready, and extensions of post‑operative stay beyond expected LOS without medical justification are considered not medically necessary.

    Retroperitoneal sarcoma resections that can be performed safely in an ambulatory surgery center with same‑day discharge or that are diagnostic procedures only (not requiring overnight recovery) do not meet inpatient admission criteria. Pre‑operative admission >1 day before surgery for non‑medical reasons is not appropriate. Continued post‑operative stays when all discharge criteria are met, stays solely for placement when medically ready, and post‑operative stays beyond the expected length of stay without documented medical necessity are considered not medically necessary.

    When sentinel node biopsy alone is performed, it is identified as an outpatient procedure and is not an inpatient indication for a full lymph node dissection. A completion or full dissection may warrant inpatient care only when clinical or anatomic factors justify inpatient recovery and monitoring; otherwise sentinel node biopsy alone should be managed as outpatient.

    Admissions or continued inpatient stays that meet any of the listed 'does not meet criteria' items are not medically necessary. These include procedures safely performed in an ambulatory surgery center with same‑day discharge, diagnostic‑only admissions that do not require overnight recovery, pre‑operative admissions >1 day before surgery for non‑medical reasons, continued post‑operative stays when all discharge criteria are met, continued stays solely awaiting facility placement when the patient is medically ready, and post‑operative stays extending beyond the expected length of stay without documented medical justification.

    Continued post‑operative inpatient stay is not appropriate when the patient has met all discharge criteria. Extending the stay beyond the expected length of stay without documentation of a medical‑necessity trigger (for example an anastomotic leak requiring intervention, postoperative ileus >5 days requiring NG decompression and TPN, surgical site infection, or postoperative hemorrhage requiring transfusion or re‑operation) places the admission at risk for denial. Documentation should support the specific clinical reason and planned intervention.

    Routine inpatient admission for primary hyperparathyroidism is not medically necessary and should be denied in the absence of hypercalcemic crisis. Inpatient parathyroidectomy is covered only when the patient meets severity criteria such as hypercalcemic crisis (serum calcium >14 mg/dL) with altered mental status, cardiac arrhythmia, dehydration requiring IV resuscitation, or when concurrent comorbidities or mediastinal exploration necessitate inpatient monitoring.

    Procedure and Diagnosis Codes

    Exploratory laparotomy: ICD-10 and CPTmixed
    R10.0acute abdomen
    K65.0generalized peritonitis
    K65.1peritoneal abscess
    S36.xinjury of intra-abdominal organs
    T14.8other injury of unspecified body region
    K63.1perforation of intestine
    49000exploratory laparotomy
    49002reopening of recent laparotomy
    49010exploration of retroperitoneum with drainage
    Exploratory laparotomy: MS-DRG / CPT crosswalkRevenue
    DRG 329-331Major Bowel Procedures (if bowel surgery performed)
    DRG 393-395Other Digestive System OR (if no bowel procedure)
    CPT 49000-49010Exploratory laparotomy CPT range
    Damage-control surgery: ICD-10 and CPTmixed
    T79.4xxAtraumatic shock
    T81.19xAother postprocedural shock
    S36.xintra-abdominal organ injury
    49000exploratory laparotomy
    49002reopening
    44602-44604bowel repair
    35221-35286vascular repair
    Damage-control surgery: MS-DRG crosswalkRevenue
    DRG 003-004Tracheostomy with MV (if prolonged)
    DRG 329-331Major Bowel (if bowel)
    DRG 957Other OR for Multiple Trauma
    MS-DRG crosswalks (exploratory laparotomy / damage-control examples)Revenue
    DRG 329-331Major Bowel Procedures (if bowel surgery performed)
    DRG 393-395Other Digestive System OR (if no bowel procedure)
    DRG 003-004Tracheostomy with MV (if prolonged)
    DRG 957Other OR for Multiple Trauma
    Retroperitoneal sarcoma: Covered CPT/Diagnosis codesmixedCovered
    C48.0Malignant neoplasm of retroperitoneum
    C49.4Malignant neoplasm of connective tissue of abdomen - soft tissue sarcoma
    D48.3Neoplasm of uncertain behavior of retroperitoneum
    CPT 49203-49215Excision retroperitoneal tumor by size (plus organ resection codes as needed)
    Pheochromocytoma: Covered CPT/Diagnosis codesmixedCovered
    E27.5Adrenomedullary hyperfunction (pheochromocytoma)
    D35.00Benign neoplasm of unspecified adrenal gland
    D35.01Benign neoplasm of right adrenal gland
    D35.02Benign neoplasm of left adrenal gland
    C74.10Malignant neoplasm of medulla of adrenal gland
    CPT 60540Adrenalectomy, open
    CPT 60545Adrenalectomy with excision of adjacent retroperitoneal tumor
    CPT 60650Laparoscopic adrenalectomy
    DRG/CPT crosswalk for pheochromocytomamixed
    DRG 628-630Other Endocrine/Nutritional Procedures
    CPT 60540-60650Adrenalectomy codes; intraoperative hemodynamic lability common
    DRG/CPT crosswalk for retroperitoneal sarcomamixed
    DRG 820-822Other OR Procedures
    DRG 329-331If bowel resected
    CPT 49203-49215Retroperitoneal tumor excision; LOS 5-10 days
    Pheochromocytoma procedure codesCPT
    60540-60650CPT range for pheochromocytoma resection (document lists range)
    Parathyroidectomy ICD-10 / CPTmixed
    E21.0Primary hyperparathyroidism
    E21.1Secondary hyperparathyroidism
    E21.2Other hyperparathyroidism
    E21.3Hyperparathyroidism unspecified
    E83.52Hypercalcemia
    60500Parathyroidectomy or exploration of parathyroid
    60502Re-exploration of parathyroid
    60505Parathyroidectomy with mediastinal exploration
    Lymph node dissection ICD-10 / CPTmixed
    C77.0Secondary malignant neoplasm of lymph nodes of head, face and neck
    C77.1Secondary malignant neoplasm of intrathoracic lymph nodes
    C77.2Secondary malignant neoplasm of intra-abdominal lymph nodes
    C77.3Secondary malignant neoplasm of axilla and upper limb lymph nodes
    C77.4Secondary malignant neoplasm of inguinal and lower limb lymph nodes
    C77.5Secondary malignant neoplasm of intrapelvic lymph nodes
    38740Axillary lymphadenectomy, complete
    38745Axillary lymphadenectomy, radical including pectoral muscles
    38760Inguinal lymphadenectomy, superficial
    38765Inguinal lymphadenectomy, superficial and deep
    1–10 of 12
    1/2
    MS-DRG crosswalks (endocrine / parathyroid)Revenue
    DRG 628-630Other Endocrine/Nutritional Procedures
    DRG 625-627Thyroid/Parathyroid Procedures
    Procedure CPT Codes (lymph node dissection range)CPT
    38740-38780CPT range for lymph node dissection procedures
    MS-DRG crosswalk examplesmixed
    DRG 582-583Breast
    DRG 740-742GYN
    DRG 656-658GU
    DRG 129-130Head & Neck
    Lethal triad physiologic thresholds
    Hypothermia< 35°C
    Acidosis (pH)< 7.2
    Coagulopathy (INR)> 1.5
    Pre-op alpha blockade duration
    Minimum duration

    Authorization, Documentation, and Billing Guidance

    Prior Authorization

    Prior authorization / utilization management

    Inpatient surgical procedures in this section are governed by Curative's utilization-management criteria; automated systems may approve but must not issue adverse determinations, and all denials require licensed clinician review.

    Prior Authorization

    Include diagnosis and CPT groups on authorization

    Include the listed diagnosis and CPT groups on surgical admission and authorization requests for retroperitoneal sarcoma and related resections: ICD-10-CM C48.0, C49.4, D48.3 and CPT 49203-49215 (plus organ resection codes as needed). For pheochromocytoma, include ICD-10-CM E27.5, D35.00-D35.02, C74.10 and CPT 60540-60650.

    • Retroperitoneal sarcoma: C48.0, C49.4, D48.3; CPT 49203-49215
    • Pheochromocytoma: E27.5, D35.00-D35.02, C74.10; CPT 60540-60650

    Clinical Background

    Exploratory laparotomy is indicated for the acute abdomen and related surgical emergencies. Typical admission indications include acute abdomen with peritonitis requiring emergent surgical exploration, penetrating abdominal trauma with hemodynamic instability or peritonitis, blunt abdominal trauma with a positive FAST exam and hemodynamic instability, radiographic pneumoperitoneum, or evisceration. Damage‑control (abbreviated) laparotomy is used for massively injured or physiologically deranged trauma patients to rapidly control hemorrhage and contamination with temporary abdominal closure and a planned return to the operating room.

    Key Definitions

    Severity of Illness (SI)
    Acute abdomen with peritonitisAlways inpatient/ICU-level severity indication
    Penetrating abdominal trauma with instability or peritonitisAlways inpatient/ICU-level severity indication
    Blunt abdominal trauma with positive FAST and hemodynamic instabilityAlways inpatient/ICU-level severity indication
    Intensity of Service (IS)
    DefinitionRequires at least one postoperative inpatient-level service (surgical procedure requiring inpatient recovery, post-op monitoring, or services not available outpatient)
    Examples of servicesHemodynamic monitoring, wound/drain management, need for ICU-level care
    Policy Summary
    Payermediviewcurative
    PolicyOther inpatient surgical procedures — exploratory laparotomy and damage-control surgery
    Policy CodePolicy N/A
    Change TypeNo material clinical or coverage changes
    Effective DateMar 4, 2026
    Last ReviewMar 4, 2026
    Next Review DateN/A
    Key ActionDocument diagnosis codes and procedure justification and include required admission or extended-stay triggers with supporting clinical evidence and a targeted intervention plan.
    SourceLink
    On This Page
    Inpatient Coverage CriteriaProcedure and Diagnosis CodesAuthorization, Documentation, and Billing GuidanceClinical BackgroundKey Definitions
    >= 14 days
    Typical agents citedphenoxybenzamine or doxazosin (per policy) followed by beta-blockade
    PurposePreoperative hemodynamic stabilization and prevention of intraoperative hypertensive crises
    Goal LOS (uncomplicated)
    Damage-control (uncomplicated)Goal LOS: 7-14 days
    Retroperitoneal sarcoma (uncomplicated)Goal LOS: 7-10 days
    SourcesEAST; MSTS/SSO; NCCN
    Serum calcium threshold for hypercalcemic crisis
    Serum calcium threshold> 14 mg/dL
    Associated featuresAltered mental status, cardiac arrhythmia, dehydration requiring IV resuscitation
    ImplicationDefines hypercalcemic crisis warranting inpatient parathyroidectomy
    Pheochromocytoma postoperative hemodynamic instability threshold
    Instability duration thresholdPost-op hemodynamic instability beyond 48 h
    Examples of triggersNeck hematoma requiring evacuation; persistent hypocalcemia requiring IV calcium; airway concerns from recurrent laryngeal nerve injury
    Documentation requirementMust document specific trigger, supporting clinical evidence, and targeted intervention plan
    Goal Length of Stay
    Goal LOS (uncomplicated standalone dissection)1-3 days
    ScopeApplies to axillary/inguinal/pelvic standalone oncologic lymph node dissection
    Sentinel node noteSentinel node biopsy alone is outpatient; full dissection inpatient status depends on extent/location
    Billing Rule

    Use provided coding crosswalks for procedures

    Use the policy's coding crosswalks when submitting authorizations and claims; crosswalks map procedure CPT ranges to MS-DRG groups for pheochromocytoma, parathyroidectomy, and lymph node dissection to support level-of-care and billing decisions.

    • Pheochromocytoma: CPT 60540-60650 → DRG 628-630
    • Parathyroidectomy: CPT 60500-60505 → DRG 625-627
    • Lymph node dissection: CPT 38740-38780 → DRG varies by primary site (e.g., 582-583, 740-742)
    Prior Authorization

    Authorizations: CPT 38740–38780 for lymph node dissection

    When requesting authorization or coding inpatient admissions for lymph node dissection, include CPT codes in the 38740–38780 range; determine inpatient versus outpatient status based on extent/location (sentinel node biopsy alone is outpatient).

    • CPT 38740-38780 should be listed on authorization/billing when applicable
    • Sentinel node biopsy alone is outpatient and should not be authorized as inpatient unless clinical/anatomic factors justify admission
    Note
    Step Therapy

    Pre-op optimization: document alpha‑blockade ≥14 days and optimization

    Document preoperative medical optimization for pheochromocytoma: adequate alpha‑blockade for ≥14 days (e.g., phenoxybenzamine or doxazosin), followed by beta‑blockade and volume expansion, and that anesthesia is experienced in pheochromocytoma management.

    • Record duration/type of alpha‑blockade (≥14 days)
    • Document subsequent beta‑blockade and volume expansion
    • Confirm anesthesia team experienced in pheochromocytoma care
    Note
    Note
    Documentation Required

    Document diagnosis, CPT(s), and justification for inpatient care

    Document diagnosis codes, operative CPT(s), and the clinical justification for inpatient-level care (severity of illness and intensity of service) on the admission and authorization.

    • Include diagnosis codes (e.g., acute abdomen, peritonitis, traumatic intra‑abdominal injury)
    • List operative CPT(s) such as 49000/49002/49010 and any bowel or vascular repairs when applicable
    • Explain why inpatient recovery/monitoring is required
    Documentation Required

    When Goal LOS is exceeded, document specified medical‑necessity triggers

    If the patient's stay exceeds the policy Goal LOS, document ONE OR MORE specified medical‑necessity triggers (e.g., anastomotic leak requiring intervention, postoperative ileus >5 days requiring NG decompression and TPN, surgical site infection, pancreatic fistula ISGPF grade B/C, bile leak requiring drainage/ERCP, or post‑op hemorrhage requiring transfusion/reoperation) with clinical evidence and a targeted intervention plan.

    • Specify which trigger is present and provide supporting clinical data
    • Describe the targeted intervention plan tied to the trigger
    Documentation Required

    Admission documentation: support both severity and intensity

    Admission for complex procedures must include documentation of both severity of illness (e.g., biopsy‑confirmed retroperitoneal sarcoma or biochemically confirmed pheochromocytoma with imaging) and intensity of service (surgical procedure requiring inpatient recovery or postoperative monitoring).

    • Attach biopsy/imaging reports confirming diagnosis and resectability
    • State the expected inpatient postoperative services or monitoring needs
    Documentation Required

    Extended‑stay documentation must identify trigger, evidence, and plan

    When Goal LOS is exceeded, documentation must state ONE OR MORE medical‑necessity triggers, identify the specific trigger, provide clinical evidence supporting it, and include a targeted intervention plan (examples include post‑op hemodynamic instability beyond 48 h for pheochromocytoma).

    • Name the trigger and link to objective findings (labs, imaging, drains, transfusions)
    • Provide a time‑bound intervention plan and responsible team
    Documentation Required

    Admission documentation must support severity and intensity (examples)

    Admission documentation must demonstrate severity of illness and intensity of service for the planned procedure (for example, biopsy‑confirmed node‑positive disease for therapeutic lymph node dissection or Ca >14 mg/dL with associated features for inpatient parathyroidectomy).

    • Include biopsy/pathology or lab thresholds (e.g., Ca >14 mg/dL) as applicable
    • Describe why postoperative inpatient recovery/monitoring is needed
    Documentation Required

    Extended stay: identify trigger(s), supporting evidence, and plan

    When Goal LOS is exceeded, the record must identify ONE OR MORE medical‑necessity triggers, provide clinical evidence supporting the trigger, and document a targeted intervention plan to address it.

    • State the specific trigger(s) present
    • Attach supporting evidence (imaging, labs, consultant notes) and intervention timeline
    Denial Risk

    Licensed clinician review required for denials

    All denials require review and sign‑off by a licensed clinician; automated systems may be used to approve but must not issue adverse determinations without clinician review.

    Denial Risk

    Denial risk: continued stay without medical justification or awaiting placement

    Continued post‑operative inpatient stay without documented medical justification, or continued stay solely to await facility placement when medically ready, is a denial trigger and may be considered not medically necessary.

    • Activate case management for discharge planning rather than inpatient extension
    • Document clinical reasons if discharge is delayed for medical necessity
    Denial Risk

    Denial for routine parathyroidectomy without hypercalcemic crisis

    Inpatient admission for routine primary hyperparathyroidism without hypercalcemic crisis (Ca ≤14 mg/dL without associated crisis features) is denied; inpatient parathyroidectomy is limited to hypercalcemic crisis or concurrent medical need.

    • Hypercalcemic crisis defined as Ca >14 mg/dL with AMS, arrhythmia, or dehydration requiring IV resuscitation and medical therapy
    Denial Risk

    Denial risk: extended post‑op stay without documented medical need

    Continued post‑operative stay beyond the expected/Goal LOS without documented medical justification, or solely to await placement, will be denied.

    • Ensure documentation of one or more accepted medical‑necessity triggers if stay exceeds Goal LOS
    Documentation Required

    Documentation + concurrent review required to avoid denial for extended stays

    Failure to document daily surgical team review and the medical‑necessity trigger(s) when Goal LOS is exceeded — including supporting evidence and a targeted intervention plan — may lead to denial under CMS 2‑midnight and inpatient payment rules.

    • Document daily surgical team notes and rationale for continued inpatient care
    • When extended stay is claimed, include trigger, evidence, and intervention plan
    Admission implicationMeets intensity requirement when any listed inpatient service is anticipated post-op
    Retroperitoneal sarcoma resection admission criteria
    Pathologic confirmationBiopsy-confirmed retroperitoneal sarcoma (e.g., liposarcoma, leiomyosarcoma, MPNST)
    ImagingCT/MRI confirming resectable disease
    Treatment standardNCCN-recommended surgical resection with goal of R0 margins and multidisciplinary tumor board review
    Pheochromocytoma pre-op optimization
    Alpha-blockade requirement>= 14 days of phenoxybenzamine or doxazosin (followed by beta-blockade and volume expansion)
    Anesthesia teamAnesthesia team experienced in pheochromocytoma management required
    DocumentationBiochemical confirmation and imaging of adrenal mass must be documented
    pheochromocytoma intraoperative risk
    Primary intraoperative riskIntraoperative hemodynamic lability is common
    Post-op implicationMay require ICU post-op for BP and glucose monitoring
    Coding noteDRG 628-630; CPT 60540-60650
    hypercalcemic crisis
    Calcium threshold> 14 mg/dL
    Associated clinical featuresAltered mental status, cardiac arrhythmia, dehydration requiring IV resuscitation and medical therapy
    Admission implicationDefines hypercalcemic crisis warranting inpatient parathyroidectomy
    Sentinel node biopsy
    Sentinel node biopsyOutpatient when performed alone
    Full dissectionMay be outpatient or inpatient depending on extent and anatomic location
    CPT rangeCPT 38740-38780